- Home
- News
- Articles+
- Aerospace
- Artificial Intelligence
- Agriculture
- Alternate Dispute Resolution
- Arbitration & Mediation
- Banking and Finance
- Bankruptcy
- Book Review
- Bribery & Corruption
- Commercial Litigation
- Competition Law
- Conference Reports
- Consumer Products
- Contract
- Corporate Governance
- Corporate Law
- Covid-19
- Cryptocurrency
- Cybersecurity
- Data Protection
- Defence
- Digital Economy
- E-commerce
- Employment Law
- Energy and Natural Resources
- Entertainment and Sports Law
- Environmental Law
- Environmental, Social, and Governance
- Foreign Direct Investment
- Food and Beverage
- Gaming
- Health Care
- IBC Diaries
- In Focus
- Inclusion & Diversity
- Insurance Law
- Intellectual Property
- International Law
- IP & Tech Era
- Know the Law
- Labour Laws
- Law & Policy and Regulation
- Litigation
- Litigation Funding
- Manufacturing
- Mergers & Acquisitions
- NFTs
- Privacy
- Private Equity
- Project Finance
- Real Estate
- Risk and Compliance
- Student Corner
- Take On Board
- Tax
- Technology Media and Telecom
- Tributes
- Viewpoint
- Zoom In
- Law Firms
- In-House
- Rankings
- E-Magazine
- Legal Era TV
- Events
- Middle East
- Africa
- News
- Articles
- Aerospace
- Artificial Intelligence
- Agriculture
- Alternate Dispute Resolution
- Arbitration & Mediation
- Banking and Finance
- Bankruptcy
- Book Review
- Bribery & Corruption
- Commercial Litigation
- Competition Law
- Conference Reports
- Consumer Products
- Contract
- Corporate Governance
- Corporate Law
- Covid-19
- Cryptocurrency
- Cybersecurity
- Data Protection
- Defence
- Digital Economy
- E-commerce
- Employment Law
- Energy and Natural Resources
- Entertainment and Sports Law
- Environmental Law
- Environmental, Social, and Governance
- Foreign Direct Investment
- Food and Beverage
- Gaming
- Health Care
- IBC Diaries
- In Focus
- Inclusion & Diversity
- Insurance Law
- Intellectual Property
- International Law
- IP & Tech Era
- Know the Law
- Labour Laws
- Law & Policy and Regulation
- Litigation
- Litigation Funding
- Manufacturing
- Mergers & Acquisitions
- NFTs
- Privacy
- Private Equity
- Project Finance
- Real Estate
- Risk and Compliance
- Student Corner
- Take On Board
- Tax
- Technology Media and Telecom
- Tributes
- Viewpoint
- Zoom In
- Law Firms
- In-House
- Rankings
- E-Magazine
- Legal Era TV
- Events
- Middle East
- Africa
Biplab Lenin
Biplab Lenin is a Partner at Cyril Amarchand Mangaldas in its Pharma, Healthcare and Life Sciences practice, with 15 years of experience at the intersections of pharmaceuticals, healthcare, biotechnology, technology, and regulatory compliance, complemented by qualifications as an engineer and a registered patent agent. His expertise spans complex regulatory frameworks for pharmaceuticals, medical devices, clinical trials, nutraceuticals, and digital health, with extensive involvement in approvals, compliance, transactions, advisory mandates, and litigation across sectors. He regularly advises on corporate and commercial matters, including the drafting, review, and negotiation of a wide range of business agreements, and plays a significant role in intellectual property strategy, patent filing and prosecution, and biodiversity regulatory advisory. Biplab is recognised across leading global legal directories-India Business Law Journal (A List 2025; Vanguards 2026; Future Legal Leader 2024), Chambers & Partners Asia Pacific (“Up and Coming” 2025 & 2026), Legal Era (“Leading Lawyer Champion” 2024 & 2025), and Legal 500 Asia Pacific (“Next Generation Partner” 2024–2026; “Key Lawyer” 2023; nominee for “Life Sciences & Healthcare Lawyer of the Year” 2024). He is also the recipient of the Young Alumni Achiever Award 2025 from the Indian Institute of Technology, Kharagpur. He serves as visiting faculty at IIM Bodh Gaya and contributes regularly as a writer and speaker on digital health, regulatory developments, and the impact of technology on the healthcare sector.

From Biplab Lenin
Digital Health in India: Catalyst for Equity or a Regulatory Time Bomb?
An analysis of India’s digital health transformation and the urgent need for a unified and adaptive regulatory framework

